Corvus Pharmaceuticals

Corvus Pharmaceuticals company information, Employees & Contact Information

Corvus is a unique environment for exceptional individuals who want to learn, contribute to an exceptional team, and make a difference in the lives of people with cancer. At Corvus, we take pride in our collaborative, community-based culture. We understand that the most successful teams are those that learn from each other and co-create in an environment that nurtures open, transparent communication.

Company Details

Employees
42
Founded
-
Address
863 Mitten Road, Suite 102, Burlingame,ca 94010,united States
Phone
(650) 900-4520
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Burlingame, CA
Looking for a particular Corvus Pharmaceuticals employee's phone or email?

Corvus Pharmaceuticals Questions

News

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 Yahoo Finance

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of - GlobeNewswire

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of GlobeNewswire

Clinical-Stage Biotech Corvus Pharmaceuticals Sets Q2 2025 Earnings Release: Key Updates Coming August 7 - Stock Titan

Clinical-Stage Biotech Corvus Pharmaceuticals Sets Q2 2025 Earnings Release: Key Updates Coming August 7 Stock Titan

Corvus Pharmaceuticals Appoints David Moore to Board of Directors - Yahoo Finance

Corvus Pharmaceuticals Appoints David Moore to Board of Directors Yahoo Finance

Corvus Pharma (NASDAQ: CRVS) to host Nov. 4 webcast for financial results update - Stock Titan

Corvus Pharma (NASDAQ: CRVS) to host Nov. 4 webcast for financial results update Stock Titan

Corvus Pharmaceuticals Announces Presentation of Interim - GlobeNewswire

Corvus Pharmaceuticals Announces Presentation of Interim GlobeNewswire

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy - Stock Titan

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy Stock Titan

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis - GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis GlobeNewswire

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases - Yahoo Finance

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases Yahoo Finance

Top Corvus Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant